PINX: SGIPF
- Last Close 44.07
- Sector Healthcare
- Industry Pharmaceutical Retailers
- Investment Style Mid Blend
- Day Range 44.07 – 44.07
- Year Range 44.07 – 76.50
- Market Cap 2.6581 Bil
- Volume / Avg 194.0 / 194.0
- Price / Sales 0.54
- Price / Book 1.75
- Forward Div Yield 1.36%
- Trailing Div Yield 181.53%
Morningstar‘s Stock Analysis SGIPF
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.
Company Profile SGIPF
Sugi Holdings Co Ltd generates revenue through pharmaceutical care in Japan. The company's drug stores sell prescription and generic drugs along with general merchandise including premium and discount groceries, discount cosmetics, pet supplies, and health supplements that are designed for self-medication. Sugi Holdings also provides disease prevention and drug delivery services. The company's Cedar Pharmacy group operates regional drugstores designed for providing health consultation. Sugi Holdings also supports regional healthcare facilities and provides at-home nursing services.
Competitors & Peers SGIPF
Morningstar does not cover competitors or peers for this firm.
FAQs for Sugi Holdings Co Ltd Stock
Yes. SGIPF has a forward dividend yield of 0.01%.
See
SGIPF’s full dividends and stock split history
on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
SGIPF’s market cap is 2.66 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
SGIPF’s stock style is Mid Core.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
SGIPF’s price/sales is 0.54.
Price/sales represents the amount an investor is willing to pay for a dollar generated from
a particular company’s sales or revenues.
SGIPF’s price/forward earnings is 18.77.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates.
The lower the Forward P/E, the cheaper the stock.
SGIPF’s price/book is 1.75.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets,
based on historical, rather than current, valuations. Historical valuations generally do not reflect
a company’s current market value. Value investors frequently look for companies that have low price/book ratios.
See SGIPF’s valuation ratios compared to the Market Index.
SGIPF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare SGIPF’s historical performance against its industry peers and the overall market.